![Curtis C. Hecht](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Curtis C. Hecht
Corporate Officer/Principal en DNA Ink LLC .
Perfil
Curtis C.
Hecht is currently a Partner at DNA Ink LLC since 2011.
He previously worked as a Director-Global Alliance at Genentech, Inc. and Hoffmann-La Roche, Inc. Curtis also served as Vice President-Business Development at inVentiv Health, Inc. from 2013 to 2014 and as Chief Business Officer at Calithera Biosciences, Inc. from 2019 to 2021.
Mr. Hecht holds an MBA from Carnegie Mellon University and Tepper School of Business, and an undergraduate degree from California State University-Sacramento.
Cargos activos de Curtis C. Hecht
Empresas | Cargo | Inicio |
---|---|---|
DNA Ink LLC | Corporate Officer/Principal | 01/03/2011 |
Antiguos cargos conocidos de Curtis C. Hecht.
Empresas | Cargo | Fin |
---|---|---|
CALITHERA BIOSCIENCES, INC. | Corporate Officer/Principal | 02/04/2021 |
inVentiv Health, Inc.
![]() inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Corporate Officer/Principal | 01/04/2014 |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formación de Curtis C. Hecht.
California State University-Sacramento | Undergraduate Degree |
Tepper School of Business | Masters Business Admin |
Carnegie Mellon University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CALITHERA BIOSCIENCES, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
DNA Ink LLC | |
inVentiv Health, Inc.
![]() inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Commercial Services |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Curtis C. Hecht